2-Deoxy-D-glucose

Biological Activity

2-Deoxy-D-glucose is a non-metabolizable glucose analog. Inhibits phosphorylation of glucose by hexokinase; causes depletion of cellular ATP. Also inhibits phosphoglucose isomerase (PGI) competitively. Causes cell cycle inhibition and cell death in in vitro models of hypoxia; blocks tumor cell growth in animal models. Also shown to induce the unfolded protein response (UPR). 2-Deoxy-D-glucose disrupts N-glycan expression on the surface of pancreatic adenocarcinoma cells. 2-Deoxy-D-glucose enhances chimeric antigen receptor T cell activity in different xenograft mouse models of pancreatic adenocarcinoma cells.

Technical Data

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.

Background References

1. 2-deoxyglucose: an anticancer and antiviral therapeutic, but not any more a low glucose mimetic.
   Kang and Hwang
   Life Sci., 2006;78:1392
2. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions.
   Maher et al.
   Cancer Chemother.Pharmacol., 2004;53:116
3. A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growth.
   Ralser et al.
   Proc.Natl.Acad.Sci.USA, 2008;105:17807

Product Datasheets